These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26469219)

  • 21. GABAergic System Dysfunction in Autism Spectrum Disorders.
    Zhao H; Mao X; Zhu C; Zou X; Peng F; Yang W; Li B; Li G; Ge T; Cui R
    Front Cell Dev Biol; 2021; 9():781327. PubMed ID: 35198562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating Mirror System (MS) Activity in Adults with ASD When Inferring Others' Intentions Using Both TMS and EEG.
    Cole EJ; Barraclough NE; Enticott PG
    J Autism Dev Disord; 2018 Jul; 48(7):2350-2367. PubMed ID: 29453710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motor Cortex Excitation/Inhibition Imbalance in Young Adults With Autism Spectrum Disorder: A MRS-TMS Approach.
    Bernardino I; Dionísio A; Violante IR; Monteiro R; Castelo-Branco M
    Front Psychiatry; 2022; 13():860448. PubMed ID: 35492696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders.
    Gao R; Penzes P
    Curr Mol Med; 2015; 15(2):146-67. PubMed ID: 25732149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders.
    El-Ansary A; Al-Ayadhi L
    J Neuroinflammation; 2014 Nov; 11():189. PubMed ID: 25407263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories.
    Canitano R; Pallagrosi M
    Front Psychiatry; 2017; 8():69. PubMed ID: 28507523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational use of event-related potentials to assess circuit integrity in ASD.
    Modi ME; Sahin M
    Nat Rev Neurol; 2017 Mar; 13(3):160-170. PubMed ID: 28211449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lateral inhibition in the autism spectrum: An SSVEP study of visual cortical lateral interactions.
    Dickinson A; Gomez R; Jones M; Zemon V; Milne E
    Neuropsychologia; 2018 Mar; 111():369-376. PubMed ID: 29458075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrinsic Visual-Motor Synchrony Correlates With Social Deficits in Autism.
    Nebel MB; Eloyan A; Nettles CA; Sweeney KL; Ament K; Ward RE; Choe AS; Barber AD; Pekar JJ; Mostofsky SH
    Biol Psychiatry; 2016 Apr; 79(8):633-41. PubMed ID: 26543004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ringing Decay of Gamma Oscillations and Transcranial Magnetic Stimulation Therapy in Autism Spectrum Disorder.
    Casanova MF; Shaban M; Ghazal M; El-Baz AS; Casanova EL; Sokhadze EM
    Appl Psychophysiol Biofeedback; 2021 Jun; 46(2):161-173. PubMed ID: 33877491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autistic spectrum disorders: A review of clinical features, theories and diagnosis.
    Fakhoury M
    Int J Dev Neurosci; 2015 Jun; 43():70-7. PubMed ID: 25862937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental changes in brain function underlying inhibitory control in autism spectrum disorders.
    Padmanabhan A; Garver K; O'Hearn K; Nawarawong N; Liu R; Minshew N; Sweeney J; Luna B
    Autism Res; 2015 Apr; 8(2):123-35. PubMed ID: 25382787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perturbed proteostasis in autism spectrum disorders.
    Louros SR; Osterweil EK
    J Neurochem; 2016 Dec; 139(6):1081-1092. PubMed ID: 27365114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell adhesion proteins and the pathogenesis of autism spectrum disorders.
    Stewart LT
    J Neurophysiol; 2015 Mar; 113(5):1283-6. PubMed ID: 24990562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigational drugs in early-stage clinical trials for autism spectrum disorder.
    Hong MP; Erickson CA
    Expert Opin Investig Drugs; 2019 Aug; 28(8):709-718. PubMed ID: 31352835
    [No Abstract]   [Full Text] [Related]  

  • 36. A synaptic trek to autism.
    Bourgeron T
    Curr Opin Neurobiol; 2009 Apr; 19(2):231-4. PubMed ID: 19545994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in neural activity when processing emotional arousal and valence in autism spectrum disorders.
    Tseng A; Wang Z; Huo Y; Goh S; Russell JA; Peterson BS
    Hum Brain Mapp; 2016 Feb; 37(2):443-61. PubMed ID: 26526072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.
    Kern JK; Geier DA; King PG; Sykes LK; Mehta JA; Geier MR
    Brain Connect; 2015 Aug; 5(6):321-35. PubMed ID: 25602622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin and excitation/inhibition balance in social recognition.
    Lopatina OL; Komleva YK; Gorina YV; Olovyannikova RY; Trufanova LV; Hashimoto T; Takahashi T; Kikuchi M; Minabe Y; Higashida H; Salmina AB
    Neuropeptides; 2018 Dec; 72():1-11. PubMed ID: 30287150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disrupted functional connectivity in dorsal and ventral attention networks during attention orienting in autism spectrum disorders.
    Fitzgerald J; Johnson K; Kehoe E; Bokde AL; Garavan H; Gallagher L; McGrath J
    Autism Res; 2015 Apr; 8(2):136-52. PubMed ID: 25428212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.